Richard Newcomb Stillwell insider trades

Open-market stock purchases and sales by Richard Newcomb Stillwell, Director at Tonix Pharmaceuticals Holding Corp, from SEC Form 4 filings since Mar 15, 2023.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -56%.

Recent trades

DateStockTradeValue
Jun 8, 2026TNXP Tonix Pharmaceuticals Holding CorpBought$58.3K
May 12, 2026TNXP Tonix Pharmaceuticals Holding CorpBought (not open market)—

Companies traded

  • TNXP Tonix Pharmaceuticals Holding Corp: 1 buy, last Jun 8, 2026

Get free alerts when Richard Newcomb Stillwell files a new trade →